William J. Link's most recent trade in Tarsus Pharmaceuticals Inc was a trade of 4,540 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tarsus Pharmaceuticals Inc | William J. Link | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 4,540 | 4,540 | - | - | Stock Option (right to buy) | |
| Tarsus Pharmaceuticals Inc | William J. Link | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jun 2025 | 3,350 | 170,448 | - | - | Common Stock | |
| Tarsus Pharmaceuticals Inc | William J. Link | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jun 2025 | 3,350 | 0 | - | - | Restricted Stock Units | |
| Tarsus Pharmaceuticals Inc | William J. Link | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 2,954 | 2,954 | - | - | Restricted Stock Units | |
| RxSight Inc | William J. Link | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 10,752 | 37,855 | - | - | Common Stock | |
| LENSAR Inc | William J. Link | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2025 | 7,374 | 550,641 | - | 0 | Common Stock | |
| Tarsus Pharmaceuticals Inc | William J. Link | Director | Other type of transaction at price $ 0.00 per share. | 12 Aug 2024 | 74,892 | 35,000 | - | 0 | Common Stock | |
| Tarsus Pharmaceuticals Inc | William J. Link | Director | Sale of securities on an exchange or to another person at price $ 26.01 per share. | 12 Aug 2024 | 29,979 | 5,021 | - | 26.0 | 779,754 | Common Stock |
| Tarsus Pharmaceuticals Inc | William J. Link | Director | Other type of transaction at price $ 0.00 per share. | 12 Aug 2024 | 27,116 | 167,098 | - | 0 | Common Stock | |
| Tarsus Pharmaceuticals Inc | William J. Link | Director | Other type of transaction at price $ 0.00 per share. | 12 Aug 2024 | 10,446 | 10,446 | - | 0 | Common Stock | |
| Tarsus Pharmaceuticals Inc | William J. Link | Director | Sale of securities on an exchange or to another person at price $ 26.53 per share. | 12 Aug 2024 | 5,021 | 0 | - | 26.5 | 133,207 | Common Stock |
| Tarsus Pharmaceuticals Inc | William J. Link | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2024 | 3,350 | 0 | - | - | Restricted Stock Units | |
| Tarsus Pharmaceuticals Inc | William J. Link | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2024 | 3,350 | 139,982 | - | - | Common Stock | |
| Tarsus Pharmaceuticals Inc | William J. Link | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
| Tarsus Pharmaceuticals Inc | William J. Link | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 3,350 | 3,350 | - | - | Restricted Stock Units | |
| RxSight Inc | William J. Link | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 2,554 | 27,103 | - | - | Common Stock | |
| LENSAR Inc | William J. Link | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 22,000 | 543,267 | - | 0 | Common Stock | |
| RxSight Inc | Link J. William | Director | Sale of securities on an exchange or to another person at price $ 49.54 per share. | 01 Feb 2024 | 20,598 | 31,900 | - | 49.5 | 1,020,456 | Common Stock |
| RxSight Inc | Link J. William | Director | Sale of securities on an exchange or to another person at price $ 50.01 per share. | 01 Feb 2024 | 7,652 | 24,248 | - | 50.0 | 382,664 | Common Stock |
| RxSight Inc | William J. Link | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Feb 2024 | 3,000 | 21,248 | - | 0 | Common Stock | |
| RxSight Inc | William J. Link | Director | Other type of transaction at price $ 0.00 per share. | 17 Aug 2023 | 694,124 | 0 | - | 0 | Common Stock | |
| RxSight Inc | William J. Link | Director | Other type of transaction at price $ 0.00 per share. | 17 Aug 2023 | 21,248 | 52,498 | - | 0 | Common Stock | |
| RxSight Inc | William J. Link | Director | Other type of transaction at price $ 0.00 per share. | 17 Aug 2023 | 2,610 | 24,549 | - | 0 | Common Stock | |
| Tarsus Pharmaceuticals Inc | William J. Link | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2023 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
| Tarsus Pharmaceuticals Inc | William J. Link | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2023 | 3,350 | 3,350 | - | - | Restricted Stock Units | |
| Tarsus Pharmaceuticals Inc | William J. Link | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2023 | 2,000 | 0 | - | - | Restricted Stock Units | |
| Tarsus Pharmaceuticals Inc | William J. Link | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2023 | 2,000 | 136,632 | - | - | Common Stock | |
| RxSight Inc | William J. Link | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 5,731 | 21,939 | - | 0 | Common Stock | |
| LENSAR Inc | William J. Link | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 33,175 | 33,175 | - | - | Stock Option (Right to Buy) | |
| LENSAR Inc | William J. Link | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 9,288 | 521,267 | - | 0 | Common Stock | |
| RxSight Inc | William J. Link | Director | Other type of transaction at price $ 0.00 per share. | 11 May 2023 | 258,390 | 0 | - | 0 | Common Stock | |
| Tarsus Pharmaceuticals Inc | William J. Link | Director | Other type of transaction at price $ 0.00 per share. | 11 May 2023 | 215,576 | 0 | - | 0 | Common Stock | |
| RxSight Inc | William J. Link | Director | Other type of transaction at price $ 0.00 per share. | 11 May 2023 | 98,715 | 694,124 | - | 0 | Common Stock | |
| Tarsus Pharmaceuticals Inc | William J. Link | Director | Other type of transaction at price $ 0.00 per share. | 11 May 2023 | 41,219 | 109,892 | - | 0 | Common Stock | |
| Tarsus Pharmaceuticals Inc | William J. Link | Director | Other type of transaction at price $ 0.00 per share. | 15 Mar 2023 | 215,575 | 215,576 | - | 0 | Common Stock | |
| Tarsus Pharmaceuticals Inc | William J. Link | Director | Other type of transaction at price $ 0.00 per share. | 15 Mar 2023 | 52,194 | 68,673 | - | 0 | Common Stock | |
| Tarsus Pharmaceuticals Inc | William J. Link | Director | Other type of transaction at price $ 0.00 per share. | 10 Nov 2022 | 215,575 | 431,151 | - | 0 | Common Stock | |
| Tarsus Pharmaceuticals Inc | William J. Link | Director | Other type of transaction at price $ 0.00 per share. | 10 Nov 2022 | 8,382 | 16,479 | - | 0 | Common Stock | |
| RxSight Inc | William J. Link | Director | Other type of transaction at price $ 0.00 per share. | 09 Nov 2022 | 316,694 | 258,390 | - | 0 | Common Stock | |
| RxSight Inc | William J. Link | Director | Other type of transaction at price $ 0.00 per share. | 09 Nov 2022 | 107,236 | 595,409 | - | 0 | Common Stock | |
| Tarsus Pharmaceuticals Inc | William J. Link | Director | Other type of transaction at price $ 0.00 per share. | 15 Aug 2022 | 215,575 | 646,726 | - | 0 | Common Stock | |
| Tarsus Pharmaceuticals Inc | William J. Link | Director | Other type of transaction at price $ 0.00 per share. | 15 Aug 2022 | 3,749 | 8,097 | - | 0 | Common Stock | |
| RxSight Inc | William J. Link | Director | Other type of transaction at price $ 0.00 per share. | 10 Aug 2022 | 316,694 | 575,084 | - | 0 | Common Stock | |
| RxSight Inc | William J. Link | Director | Other type of transaction at price $ 0.00 per share. | 10 Aug 2022 | 107,236 | 488,173 | - | 0 | Common Stock | |
| Tarsus Pharmaceuticals Inc | William J. Link | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 7,000 | 7,000 | - | - | Stock Option (right to buy) | |
| Tarsus Pharmaceuticals Inc | William J. Link | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 2,000 | 2,000 | - | - | Restricted Stock Units | |
| RxSight Inc | William J. Link | Director | Other type of transaction at price $ 0.00 per share. | 08 Jun 2022 | 375,000 | 891,778 | - | 0 | Common Stock | |
| RxSight Inc | William J. Link | Director | Other type of transaction at price $ 0.00 per share. | 08 Jun 2022 | 126,979 | 380,937 | - | 0 | Common Stock | |
| LENSAR Inc | William J. Link | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 15,616 | 15,616 | - | - | Stock Option (Right to Buy) | |
| LENSAR Inc | William J. Link | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 4,285 | 511,979 | - | 0 | Common Stock | |
| RxSight Inc | William J. Link | Director | Other type of transaction at price $ 0.00 per share. | 17 May 2022 | 126,979 | 253,958 | - | 0 | Common Stock | |
| RxSight Inc | William J. Link | Director | Other type of transaction at price $ 0.00 per share. | 15 Mar 2022 | 126,979 | 126,979 | - | 0 | Common Stock | |
| Tarsus Pharmaceuticals Inc | William J. Link | Director | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 250,000 | 862,301 | - | 0 | Common Stock | |
| Tarsus Pharmaceuticals Inc | William J. Link | Director | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 4,348 | 4,348 | - | 0 | Common Stock | |
| RxSight Inc | William J. Link | Director, Ten Percent Owner | 03 Aug 2021 | 2,016,778 | 0 | - | - | Series H Preferred Stock | ||
| RxSight Inc | William J. Link | Director, Ten Percent Owner | 03 Aug 2021 | 2,016,778 | 2,016,778 | - | 0 | Common Stock | ||
| RxSight Inc | William J. Link | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 03 Aug 2021 | 31,250 | 37,109 | - | 16 | 500,000 | Common Stock |
| RxSight Inc | William J. Link | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2021 | 5,859 | 5,859 | - | 0 | Common Stock | |
| Tarsus Pharmaceuticals Inc | William J. Link | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Tarsus Pharmaceuticals Inc | William J. Link | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Glaukos Corporation | William J. Link | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2021 | 2,382 | 17,821 (0%) | 0% | 0 | Common Stock | |
| LENSAR Inc | William J. Link | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 20,847 | 20,847 | - | - | Stock Option (Right to Buy) | |
| LENSAR Inc | William J. Link | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Dec 2020 | 80,157 | 507,694 | - | 0 | Common Stock | |
| Glaukos Corporation | William J. Link | Director | Sale of securities on an exchange or to another person at price $ 67.96 per share. | 01 Dec 2020 | 49,400 | 16,039 (0%) | 0% | 68.0 | 3,357,091 | Common Stock |
| Glaukos Corporation | William J. Link | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 32.00 per share. | 01 Dec 2020 | 25,000 | 50,439 (0%) | 0% | 32 | 800,000 | Common Stock |
| Glaukos Corporation | William J. Link | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2020 | 25,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Glaukos Corporation | William J. Link | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2020 | 15,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Glaukos Corporation | William J. Link | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.69 per share. | 01 Dec 2020 | 15,000 | 65,439 (0%) | 0% | 24.7 | 370,350 | Common Stock |
| Glaukos Corporation | William J. Link | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2020 | 10,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Glaukos Corporation | William J. Link | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.28 per share. | 01 Dec 2020 | 10,000 | 25,439 (0%) | 0% | 7.3 | 72,750 | Common Stock |
| Glaukos Corporation | William J. Link | Director | Sale of securities on an exchange or to another person at price $ 68.72 per share. | 01 Dec 2020 | 600 | 15,439 (0%) | 0% | 68.7 | 41,232 | Common Stock |
| Tarsus Pharmaceuticals Inc | William J. Link | Director | 20 Oct 2020 | 1,112,301 | 1,112,301 | - | - | Common Stock | ||
| Tarsus Pharmaceuticals Inc | William J. Link | Director | 20 Oct 2020 | 1,112,301 | 0 | - | - | Series B Preferred Stock |